Theragen Genome Care
GenomeCare is a leading prenatal genetic analysis company founded in 2012, providing advanced genetic testing services based on next-generation sequencing (NGS) and proprietary AI algorithms. The company offers innovative prenatal diagnostic solutions such as Precision GenoMom (E-NIPT), GenoBro (PGT), GenoVennet (NBS), GenoFind (NGS), and ORA, serving expectant parents globally through obstetrics and IVF centers. GenomeCare differentiates itself with patented NGS-based fetal chromosomal aneuploidy detection technology and a strong focus on bioinformatics, delivering high-reliability genetic tests for both high- and low-risk pregnancies. The company maintains A-grade quality evaluations and has expanded its market presence with technology exports to the Middle East and Vietnam, supported by ongoing research collaborations and intellectual property development.
Theragen Genome Care
GenomeCare is a leading prenatal genetic analysis company founded in 2012, providing advanced genetic testing services based on next-generation sequencing (NGS) and proprietary AI algorithms. The company offers innovative prenatal diagnostic solutions such as Precision GenoMom (E-NIPT), GenoBro (PGT), GenoVennet (NBS), GenoFind (NGS), and ORA, serving expectant parents globally through obstetrics and IVF centers. GenomeCare differentiates itself with patented NGS-based fetal chromosomal aneuploidy detection technology and a strong focus on bioinformatics, delivering high-reliability genetic tests for both high- and low-risk pregnancies. The company maintains A-grade quality evaluations and has expanded its market presence with technology exports to the Middle East and Vietnam, supported by ongoing research collaborations and intellectual property development.